About Immodulon therapeutics limited

About company

Immodulon is a privately-owned immuno-oncology company primarily focused on the development of novel, safe, effective and potentially valuable treatments for cancer. Their IMM-101 based immunotherapy complements other cancer therapies, including immune checkpoint inhibitors and chemotherapy. They are currently developing treatments for advanced melanoma, a skin cancer, and for advanced pancreatic cancer.